Viewpoint. Albumin and hypovolaemia: is the Cochrane evidence to be trusted?
| Publicado en: | Lancet Vol. 359; no. 9300; pp. 70 - 73 |
|---|---|
| Autor principal: | |
| Formato: | tables/charts Journal Article |
| Publicado: |
Lancet
1/5/2002
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106933069&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106933069 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 1/5/2002 vid: 359 iid: 9300 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 106933069 106933069 2002064859 10.1016/s0140-6736(02)07285-9 NLM11809206 106933069 ppf: 70 ppct: 3 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Viewpoint. Albumin and hypovolaemia: is the Cochrane evidence to be trusted? aug: au: Horsey P sug: subj: Albumins Adverse Effects Albumins Therapeutic Use Critically Ill Patients Systematic Review Methods Blood Volume Clinical Trials Cochrane Library Fluid Therapy Mortality Shock, Hemorrhagic Prevention and Control pubtype: Academic Journal doctype: tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|